These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 26257254

  • 1. Association of adult attention deficit hyperactivity disorder subtypes and response to methylphenidate HCL treatment: A magnetic resonance spectroscopy study.
    Unal GA, Kenar AN, Herken H, Kiroglu Y.
    Neurosci Lett; 2015 Sep 14; 604():188-92. PubMed ID: 26257254
    [Abstract] [Full Text] [Related]

  • 2. Effects of methylphenidate treatment on the cerebellum in adult attention-deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
    Inci Kenar AN, Unal GA, Kiroglu Y, Herken H.
    Eur Rev Med Pharmacol Sci; 2017 Jan 14; 21(2):383-388. PubMed ID: 28165547
    [Abstract] [Full Text] [Related]

  • 3. Relationship between the DAT1 gene and the effects of methylphenidate administration in adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
    Inci Kenar AN, Ünal GA, Güler H, Albuz B, Kıroğlu Y, Erdal ME, Herken H.
    Eur Rev Med Pharmacol Sci; 2016 Apr 14; 20(7):1373-8. PubMed ID: 27097961
    [Abstract] [Full Text] [Related]

  • 4. Relationship between the SNAP-25 gene and the effects of methylphenidate on the anterior cingulate cortex of patients with adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
    Ünal GA, İnci Kenar AN, Tepeli E, Kıroğlu Y, Herken H.
    Eur Rev Med Pharmacol Sci; 2016 Jun 14; 20(11):2443-9. PubMed ID: 27338073
    [Abstract] [Full Text] [Related]

  • 5. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
    Husarova V, Bittsansky M, Ondrejka I, Dobrota D.
    Psychiatry Res; 2014 Apr 30; 222(1-2):75-83. PubMed ID: 24679996
    [Abstract] [Full Text] [Related]

  • 6. Effect of 12-week administration of 20-mg long-acting methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr ratios in the prefrontal cortices of school-age children in Indonesia: a study using 1H magnetic resonance spectroscopy (MRS).
    Wiguna T, Guerrero AP, Wibisono S, Sastroasmoro S.
    Clin Neuropharmacol; 2012 Apr 30; 35(2):81-5. PubMed ID: 22318191
    [Abstract] [Full Text] [Related]

  • 7. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder.
    Carrey NJ, MacMaster FP, Gaudet L, Schmidt MH.
    J Child Adolesc Psychopharmacol; 2007 Feb 30; 17(1):11-7. PubMed ID: 17343550
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
    Kim H, Heo HI, Kim DH, Ko IG, Lee SS, Kim SE, Kim BK, Kim TW, Ji ES, Kim JD, Shin MS, Choi YW, Kim CJ.
    Neurosci Lett; 2011 Oct 17; 504(1):35-9. PubMed ID: 21907264
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
    Somkuwar SS, Kantak KM, Dwoskin LP.
    J Neurosci Methods; 2015 Aug 30; 252():55-63. PubMed ID: 25680322
    [Abstract] [Full Text] [Related]

  • 14. Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder -- a magnet resonance spectroscopy study.
    Perlov E, Philipsen A, Hesslinger B, Buechert M, Ahrendts J, Feige B, Bubl E, Hennig J, Ebert D, Tebartz van Elst L.
    J Psychiatr Res; 2007 Dec 30; 41(11):934-41. PubMed ID: 17303167
    [Abstract] [Full Text] [Related]

  • 15. Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series.
    Carrey N, MacMaster FP, Sparkes SJ, Khan SC, Kusumakar V.
    J Child Adolesc Psychopharmacol; 2002 Dec 30; 12(4):331-6. PubMed ID: 12625993
    [Abstract] [Full Text] [Related]

  • 16. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K, Halari R, Cubillo A, Mohammad AM, Brammer M, Taylor E.
    Neuropharmacology; 2009 Dec 30; 57(7-8):640-52. PubMed ID: 19715709
    [Abstract] [Full Text] [Related]

  • 17. Clinically-oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS.
    Monden Y, Dan H, Nagashima M, Dan I, Kyutoku Y, Okamoto M, Yamagata T, Momoi MY, Watanabe E.
    Clin Neurophysiol; 2012 Jun 30; 123(6):1147-57. PubMed ID: 22088661
    [Abstract] [Full Text] [Related]

  • 18. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP, Fan J, Bédard AC, Clerkin SM, Ivanov I, Tang CY, Halperin JM, Newcorn JH.
    Arch Gen Psychiatry; 2012 Sep 30; 69(9):952-61. PubMed ID: 22945622
    [Abstract] [Full Text] [Related]

  • 19. The influence of methylphenidate on the power spectrum of ADHD children - an MEG study.
    Wienbruch C, Paul I, Bauer S, Kivelitz H.
    BMC Psychiatry; 2005 Jul 26; 5():29. PubMed ID: 16042816
    [Abstract] [Full Text] [Related]

  • 20. Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality.
    Zang YF, Jin Z, Weng XC, Zhang L, Zeng YW, Yang L, Wang YF, Seidman LJ, Faraone SV.
    Brain Dev; 2005 Dec 26; 27(8):544-50. PubMed ID: 15876503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.